Crossmark

A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition

Crossref DOI link: https://doi.org/10.1038/nm.4170

Published Online: 2016-08-15

Published Print: 2016-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Traxler, Elizabeth A

Yao, Yu

Wang, Yong-Dong https://orcid.org/0000-0001-8751-9216
Woodard, Kaitly J

Kurita, Ryo

Nakamura, Yukio

Hughes, Jim R

Hardison, Ross C https://orcid.org/0000-0003-4084-7516
Blobel, Gerd A

Li, Chunliang

Weiss, Mitchell J https://orcid.org/0000-0002-6734-4858
License Information

Text and Data Mining valid from 2016-08-15
More Information

Article History

Received: 28 January 2016

Accepted: 22 July 2016

First Online: 15 August 2016

Competing interests

: The authors declare no competing financial interests.